Next Science Ltd (AU:NXS) has released an update.
Next Science Limited has announced a study showcasing the significant reduction of infection rates in Total Knee Arthroplasty procedures using their XPERIENCE™ surgical irrigant. Published in the Journal of Surgical Infections, the study evidences a promising decrease in periprosthetic joint infection, reinforcing the product’s potential as part of a comprehensive infection prevention strategy. This marks another step in the company’s commitment to improving patient outcomes through its innovative XBIO™ technology.
For further insights into AU:NXS stock, check out TipRanks’ Stock Analysis page.
